T863
T-863 is a potent and selective oral DGAT1 inhibitor that binds the enzyme's acyl-CoA site to block cellular triacylglycerol synthesis. It has demonstrated efficacy in obese mouse models, reducing body weight, lowering hepatic and serum triglycerides, and improving insulin sensitivity, supporting its use in metabolic disease research.
Product Specifications
CAS Number
701232-20-4
Product Name Alternative
Inhibit, Inhibitor, mono- acylglycerol acyltransferase, Diacylglycerol acyltransferase, DGAT3, DGAT-3, DGAT-1 inhibitor, DGAT1, DGAT 3, Diglyceride acyltransferase, acyl-CoA:cholesterol acyltransferase, Acyltransferase, T863, T-863, T 863
Field of Research
Metabolism Research
Purity
98.66% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (5.07 mM) ; DMSO:41.67 mg/mL (105.64 mM)
Smiles
CC1 (C) Oc2ncnc (N) c2N=C1c1ccc (cc1) [C@H]1CC[C@H] (CC (O) =O) CC1
Molecular Formula
C22H26N4O3
Molecular Weight
394.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC1022781 1 Each
2- (2-Butoxy-6-fluorophenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Sign In for Pricing
View Details MBS6332974-01 0.1 mL
PGAP2, CT (PGAP2, FRAG1, Post-GPI attachment to proteins factor 2, FGF receptor-activating protein 1) (MaxLight 405)
Sign In for Pricing
View Details MBS6332974-02 5x 0.1 mL
PGAP2, CT (PGAP2, FRAG1, Post-GPI attachment to proteins factor 2, FGF receptor-activating protein 1) (MaxLight 405)
Sign In for Pricing
View Details